Which of the following opioids undergoes minimal hepatic metabolism and is therefore preferred in patients with severe liver disease?

Explanation

## Opioid Metabolism and Hepatic Clearance **Key Point:** Fentanyl undergoes minimal first-pass hepatic metabolism and is widely preferred in patients with severe liver disease, particularly via transdermal or parenteral routes that bypass hepatic first-pass effect entirely. ### Opioid Metabolism Comparison | Opioid | Hepatic Metabolism | Elimination Route | Use in Liver Disease | |--------|-------------------|-------------------|----------------------| | **Fentanyl** | Minimal first-pass; CYP3A4 (low extraction ratio via systemic route) | Renal excretion of inactive metabolites | **PREFERRED** — minimal hepatic dependence; transdermal/IV routes bypass first-pass | | **Morphine** | Significant hepatic conjugation (glucuronidation); high first-pass effect | Renal excretion of active metabolites (M6G) | Caution — active metabolite M6G accumulates in renal failure (common in cirrhosis); risk of hepatic encephalopathy | | **Codeine** | ~90% hepatic (CYP2D6) — prodrug requiring hepatic activation | Renal excretion of metabolites | Avoid — unpredictable activation; extensive hepatic dependence | | **Methadone** | ~90% hepatic (CYP3A4, 2D6) | Renal/fecal excretion of metabolites | Avoid — extensive hepatic metabolism; prolonged half-life risk | **High-Yield:** Fentanyl is preferred in severe liver disease because: - It has a **low hepatic extraction ratio** when given systemically, meaning hepatic dysfunction does not dramatically alter its clearance - Its metabolites (norfentanyl) are **pharmacologically inactive**, avoiding toxic metabolite accumulation - Transdermal and IV routes **bypass first-pass hepatic metabolism** entirely - It does NOT produce active metabolites that accumulate in renal failure **Clinical Pearl (KD Tripathi / Harrison):** Morphine undergoes significant glucuronidation to morphine-6-glucuronide (M6G), an active metabolite that accumulates in renal impairment — a condition frequently co-existing with cirrhosis (hepatorenal syndrome). This makes morphine a riskier choice in advanced liver disease compared to fentanyl. **Warning:** Do NOT confuse "minimal first-pass metabolism" with "no hepatic metabolism." Fentanyl is still metabolized by CYP3A4 systemically, but its low extraction ratio and inactive metabolites make it far safer than morphine, codeine, or methadone in hepatic impairment.